MHRA Warns of Rare Severe Pancreatitis With GLP-1 Drugs
The Medicines and Healthcare products Regulatory Agency (MHRA) has updated the product information for GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists to reflect a small risk of severe acute pancreatitis. The regulator issued a new drug safety update after receiving rare reports of necrotising and fatal pancreatitis linked to the medicines. Information for both patients and […]
MHRA Warns of Rare Severe Pancreatitis With GLP-1 Drugs Read More »
